International Cannabrands Announces Financing Engagement Co-Led by Gravitas Securities and Canaccord Genuity
Not for Dissemination to United States Newswire Services or for Dissemination in the United States CALGARY, AB / ACCESSWIRE /...
user
Calidi Biotherapeutics Announces Global Oncolytic Virus-based Immunotherapy License to VetStem Biopharma for its Pioneering Treatment of Cancer in the Veterinary Field
SAN DIEGO, CA / ACCESSWIRE / July 10, 2019 / Calidi Biotherapeutics, Inc., a clinical‐stage biotechnology company at the forefront...
Biom’up Provides Business Update for the First Half of 2019 and confirms its Revenue Guidance for the year
Global, unaudited sales of HEMOBLAST(TM) Bellows for the first half of 2019 were EUR1.4 million - on track to achieve...
Kadmon Doses First Patient in Phase 2 Clinical Trial of KD025 in Systemic Sclerosis
NEW YORK, NY / ACCESSWIRE / July 9, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that the first...
StageZero Life Sciences Expands Salesforce Through Collaboration with Coastal Medical
TORONTO, ON / ACCESSWIRE / July 9, 2019 / StageZero Life Sciences ("StageZero" or the "Company") (TSX: SZLS) today announced...
AiCuris and Lysando Join Forces in the Fight Against Antimicrobial Resistance
Cooperation focused on the joint development and optimization of human anti-infective drug candidates against gram-negative and gram-positive bacteria in relevant...
Heat Biologics Completes Enrollment in Phase 2 Non-Small Cell Lung Cancer Trial
DURHAM, NC / ACCESSWIRE / July 9, 2019 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing therapies designed...
NeoGenomics to Build State-of-the-Art Oncology Laboratory and Global Headquarters in Fort Myers, Florida
FT. MYERS, FL / ACCESSWIRE / July 9, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic...
EyeGate Files FDA Submission to Initiate PE Pilot Study
WALTHAM, MA / ACCESSWIRE / July 9, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) ("EyeGate" or "the Company"), a clinical-stage...
ITOCO and Mountain Trading SAS Sign JV to Expand CBD Potential in Colombia
TORONTO, ON / ACCESSWIRE / July 9, 2019 / ITOCO INC. (OTC Pink: ITMC) is pleased to announce it has...
Intellipharmaceutics International Inc. Announces $10,000,000 Equity Financing Commitment
TORONTO, ON / ACCESSWIRE / July 8, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX: IPCI) ("Intellipharmaceutics" or the...
MorphoSys and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibitors of CD47-SIRP alpha Signaling in Immuno-Oncology
PLANEGG, MUNICH and HALLE (SAALE), GERMANY / ACCESSWIRE / July 8, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment;...
Indo Global Exchange(s) Pte Ltd Announces Shareholder Update
New CEO Introduces Operational Strategy CLOVERDALE, CA / ACCESSWIRE / July 8, 2019 / Indo Global Exchange(s) Pte Ltd (USOTC:...
Advanzeon Solutions, Inc.’s Wholly Owned Subsidiary’s SleepMaster Solutions (TM) Sleep Apnea Program has been Selected by All Aboard America! for its Drivers and Employees
TAMPA, FL / ACCESSWIRE / July 8, 2019 / Advanzeon Solutions, Inc. (OTC PINK: CHCR) ("Advanzeon") announced today that its...
Sterna Biologicals Strengthens Management Team To Progress Towards Phase IIb Development
Industry veteran Dr. Marion Wencker strengthens sterna's management team as consulting CMO Financial expert Dr. Thomas Klaue recently joined sterna...
Avinger Announces Commercial Launch of Ocelot in Australia
First Patients Treated Successfully in Australia with Image-Guided CTO-Crossing Device REDWOOD, CA / ACCESSWIRE / July 8, 2019 / Avinger,...
Aytu BioScience Announces Publication of Clinical Study Results Demonstrating Effectiveness of Natesto(R) Regardless of Patients’ Baseline Hypogonadism Severity
First Natesto Study to Demonstrate Efficacy in Severely Hypogonadal Patients ENGLEWOOD, CO / ACCESSWIRE / July 8, 2019 / Aytu...
Evotec And Venture Capital Consortium Form ‘Breakpoint Therapeutics Gmbh’
PORTFOLIO OF DRUG DISCOVERY PROJECTS TARGETING DNA DAMAGE RESPONSES ("DDR"), A HIGHLY PROMISING APPROACH TO TREAT CANCER PATIENTS BREAKPOINT THERAPEUTICS...
EastWest Bioscience Reports Third Quarter 2019 Financial Results
VANCOUVER, BC / ACCESSWIRE / July 4, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) expands on its...
Experion Holdings Ltd. Trading on Frankfurt Stock Exchange Under New Company Name
VANCOUVER, BC / ACCESSWIRE / July 3, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP) (OTCQB:EXPFF) (FRANKFURT:MB31),...